Literature DB >> 32205064

Hospital acquired viral respiratory tract infections: An underrecognized nosocomial infection.

Naveen Manchal1, Mohamed Reffai Syed Mohamed2, Michael Ting3, Hugh Luetchford4, Fleur Francis5, Janine Carrucan6, Robert Norton7.   

Abstract

BACKGROUND: Our study aimed to describe the incidence, epidemiology of respiratory viruses and outcomes in hospital acquired viral respiratory infections (HAVRI).
METHODS: We conducted a retrospective observational study on all adults and children with hospital acquired viral respiratory infections between July 2012 and April 2019. Clinical and microbiological data were collected in a major tertiary level hospital in North Queensland. Morbidity indicators were the length of stay, need for intensive care and mechanical ventilation. Length of stay was analyzed with the Kruskal-Wallis test and mortality with the Chi-Square test.
RESULTS: A total of 283 patients tested positive for a respiratory virus and fulfilled the criteria for a hospital acquired infection. Individuals in the younger age group were more likely to be admitted to intensive care and need mechanical ventilation. A higher mortality was found with individuals in the older age category. The morbidity and mortality did not differ based on the virus type. Influenza A was the most common respiratory virus associated with hospital acquired viral respiratory infections.
CONCLUSION: Hospital acquired viral respiratory infections contribute significantly to morbidity and mortality regardless of the virus species. Crown
Copyright © 2020. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cross infection; Lung; Viral infections

Mesh:

Year:  2020        PMID: 32205064     DOI: 10.1016/j.idh.2020.02.002

Source DB:  PubMed          Journal:  Infect Dis Health        ISSN: 2468-0451


  1 in total

1.  Synthesis of covalent bonding MWCNT-oligoethylene linezolid conjugates and their antibacterial activity against bacterial strains.

Authors:  José A Alatorre-Barajas; Eleazar Alcántar-Zavala; M Graciela Gil-Rivas; Edgar Estrada-Zavala; Adrián Ochoa-Terán; Y Gochi-Ponce; Julio Montes-Ávila; Alberto Cabrera; Balter Trujillo-Navarrete; Yazmin Yorely Rivera-Lugo; Gabriel Alonso-Núñez; Edgar A Reynoso-Soto; J L Medina-Franco
Journal:  RSC Adv       Date:  2021-08-31       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.